(Q35157558)

6 August 2017

1 reference

title

Clinical trials of transplant tolerance: slow but steady progress (English)

1 reference

6 August 2017

Jeffrey B Matthews

1

1 reference

6 August 2017

Eleanor Ramos

series ordinal

2

1 reference

6 August 2017

Jeffrey A Bluestone

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

794-803

1 reference

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Mechanisms of transplant tolerance induction using costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

What's in the pipeline? New immunosuppressive drugs in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Preclinical assessment of anti-CD40 Mab 5D12 in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Mechanisms of tolerance induction: blockade of co-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Natalizumab for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Tolerance through bone marrow transplantation with costimulation blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Glycoproteins of murine thymocyte and splenocyte surface membranes; binding to concanavalin A and recognition by heterologous antilymphocyte serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.0154.X

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/00007890-200006270-00007

Identifiers

DOI

10.1046/J.1600-6135.2003.0154.X

1 reference

release_47v4fu6dmnaudgkyeeegxbflzu

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/47v4fu6dmnaudgkyeeegxbflzu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference